Watch more of our videos on ShotsTV.com  and on Freeview 262 or Freely 565 Visit Shots! now Lobular breast cancer is the 5th most common form of female cancer yet it does not have its own specific treatment and remains an unmet clinical need. In 2023, …

The AIM-traded firm said the study, an interventional phase one clinical trial, investigated the use of the FDA-approved drug digoxin in treating metastatic breast cancer patients. It said the Parsortix system was instrumental in selecting patients for the …

… $3.3 million toward groundbreaking breast cancer research, and provided more than $6 …

… Deegan, has raised millions for breast cancer research and support since its launch …

… Cancer Centre and the Leeds Breast Cancer Research Group, via the Leeds Hospitals … valuable support that the Leeds Breast Cancer Research Group offers.” The Square Ball …

… inhibitors. Roche has been advancing breast cancer research for more than 30 years …

… health organizations such as the Breast Cancer Research Foundation, Johns Hopkins University, the …

… this will be split between Breast Cancer Research and the school’s Eco …

… for patients. Recent advancements in breast cancer research have led to significant progress …

… Cancer Genentech has been advancing breast cancer research for more than 30 years …